The idea is that the companies can work closely with leaders from the University of Texas and access Dell Med’s full range of facilities, innovation teams and faculty, while being supported by ABHI’s network of connections across Texas’ four major cities. The companies can also take advantage of ABHI’s healthtech network, including investors, hospital systems, chambers of commerce and key business groups.

The Hub is part of ABHI’s broader US accelerator programme, which also includes two tailored trade missions to key US healthtech hubs, developed to forge and develop partnerships with leading clinical communities. “We are deeply supportive of the work ABHI is doing to assist UK companies with their export strategies, and the ABHI Innovation Hub is a prime opportunity for businesses to develop operations stateside,” said Jackie Fielding, Regional Vice-President for Medtronic and Vice Chair of the ABHI Board of Directors. “On behalf of the ABHI Board, I am delighted with how well the US Accelerator Programme is going and we are proud to be developing these two-way trading partnerships.”

Ruben Rathnasingham, Assistant Dean for Health, Product Innovation at Dell Medical School, said: “Since the launch of the ABHI Innovation Hub at Dell Med, we have met with, and learned from, numerous small and large UK businesses, academic medical centres and health systems. We have helped several UK-based businesses connect with key US market leaders and are also in active partnership discussions with UK-based start-ups who now have a presence in Austin. ABHI’s International Program, that supports US-based companies enter and explore the UK market, has been a further value-driver for our partnership."